Enyo aims for Phase II HBV, NASH trials with €40M round

By Paul Bonanos | Jun 8, 2018 | 3:22 PM GMT

Enyo Pharma S.A. (Lyon, France) raised €40 million ($46.8 million) in a series B round led by